This is an easy read document about the standard. The standard is to help everyone know how and when to use psychotropic medicines.

A presentation by Mr Bronte Parkin on Polypharmacy Consumer Perspective.

On 21 March 2022, the Australian Commission on Safety and Quality in Health Care, the Aged Care Quality and Safety Commission and the NDIS Quality and Safeguards Commission have launched the Joint Statement on the important issue of inappropriate use of psychotropic medicines with people with disability and older people as a form of restrictive...

This resource accompanies the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard. It describes what the quality statements mean for healthcare services and provides indicators to support local quality improvement activity.

Psychotropic medicines are commonly prescribed to people with cognitive disability or impairment, including older people with dementia and people of all ages with intellectual disability, autism spectrum disorder and other neurodevelopmental conditions. Psychotropic medicine use in these populations is disproportionately high, reflecting a...

A list of members in the Topic Working Group supporting the development of the clinical care standard aiming to reduce inappropriate use of psychotropic medicines for behaviour.